✦ LIBER ✦

The pharmacology of carvedilol

✍ Scribed by R. R. Ruffolo; M. Gellai; J. P. Hieble; R. N. Willette; A. J. Nichols

Publisher: Springer
Year: 1990
Tongue: English
Weight: 616 KB
Volume: 38
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf01409471

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of carvedilol

✍ Tomlinson, B. ;Prichard, B.N.C. ;Graham, B.R. ;Walden, R.J. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 922 KB

Animal work has shown that carvedilol is a nonselective beta-blocking drug. It has a vasodilator action from alpha-receptor blockade, but there is evidence that it has further action to relax smooth muscle, possibly from calcium channel antagonism. Carvedilol is lipid soluble and 25% bioavailable, a

Pharmacological characteristics of the s

Pharmacological characteristics of the stereoisomers of carvedilol

✍ W. Bartsch; G. Sponer; K. Strein; B. Müller-Beckmann; L. Kling; E. Böhm; U. Mart 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 318 KB

Effects of carvedilol on adrenergic rece

Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes

✍ Bristow, M.R. ;Larrabee, P. ;M�ller-Beckmann, B. ;Minobe, W. ;Roden, R. ;Skerl, 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 778 KB

Carvedilol, a new beta-blocker with vasodilating properties due to alpha 1-blockade, was investigated in preparations of human ventricular myocardium. Carvedilol demonstrated a high affinity and is a slightly beta 1-selective competitive beta-blocking agent, with a KD for beta 1-receptors of approxi

Carvedilol

📂 Article 📅 1999 🏛 Prelum Uitgevers ⚖ 58 KB

Pharmacological profile of ?-adrenocepto

Pharmacological profile of ?-adrenoceptor blockers with vasodilating properties, especially carvedilol ? rationale for clinical use

✍ Sponer, G. ;Bartsch, W. ;Strem, K. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 750 KB

The rationale for the combined use of beta-adrenoceptor antagonists and vasodilators is to improve the efficacy of the antihypertensive therapy and to reduce the incidence of side effects. If suitable coagents are selected and used at appropriate doses, the disadvantages of each separate component (

Carvedilol and the kidney

✍ Dupont, A.G. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 565 KB

Antihypertensive drugs have differing effects on renal hemodynamics, tubular function, plasma electrolytes, and hormonal responses. Nonselective beta-blockers without intrinsic sympathomimetic activities, such as propranolol, have been reported to reduce renal blood flow and to cause a modest decrea